NEW YORK, NY / ACCESSWIRE / November 17, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ignyta Inc. (NASDAQ: RXDX), KongZhong Corp (NASDAQ: KZ), Arbutus Biopharma Corp (NASDAQ: ABUS) and Curis Inc. (NASDAQ: CRIS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
RXDX Research Package: http://www.traders-choice.com/pdf?s=RXDX
KZ Research Package: http://www.traders-choice.com/pdf?s=KZ
ABUS Research Package: http://www.traders-choice.com/pdf?s=ABUS
CRIS Research Package: http://www.traders-choice.com/pdf?s=CRIS
============
Highlights from today's reports include:
On Monday, November 16, 2015, Nasdaq Composite ended at 4,984.62, up 1.15%, Dow Jones Industrial Average advanced 1.38% to finish the day at 17,483.01, and S&P 500 closed at 2,053.19, up 1.49%.
- The stock of Ignyta Inc. lost 1.72% to close Monday's session at USD 12.02. The shares of the company moved in a range of USD 11.60 and USD 12.52. A trading volume of 0.17 million shares was recorded, which was lower than its 150-day daily average volume of 0.40 million shares and 52-week average volume of 0.26 million shares. Over the last five days Ignyta Inc.'s shares have advanced 13.93% and in the past one month the stock has gained a momentum of 6.09%. Additionally, over the last three months the stock has declined 12.77% while in the past six months the shares have registered a gain of 31.37%. The company has returned 2.47% in the past one month, on a compounded total return basis. The company has a market capitalization of USD 356.03 million. The company stock is trading 12.01% above its 20-day simple moving average.
- KongZhong Corp's stock remained flat to close Monday's session at USD 6.92. The company's shares fluctuated in a range of USD 6.85 and USD 6.94. A total of 0.09 million shares exchanged hands, which was lesser than its 52-week average volume of 0.14 million shares. Over the last three days KongZhong Corp's shares have declined by 0.43% while in the past one week the stock has moved insignificantly and remained flat over the period. Furthermore, over the last three months the stock has lost 3.08% while in the past six months the shares have picked up 9.49%. The company has returned 8.63% in the last half year, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 73.93, which compares to a historical PE ratio of 11.23. The company stock is trading at a price to sales ratio of 1.48 while price to book ratio stood at 2.40. The company has a market capitalization of USD 322.82 million.
- Arbutus Biopharma Corp's stock slipped by 3.76% to close Monday's session at USD 5.38. The company's shares oscillated between USD 5.26 and USD 5.68, marking a new 52-week low during the session. The stock recorded a trading volume of 0.34 million shares, which was below its 50-day daily average volume of 0.39 million shares and 52-week average volume of 0.70 million shares. Over the last five days Arbutus Biopharma Corp's shares have declined by 11.51% and in the past one month the stock has lost 10.93%. In addition, the company stock is trading at a price to book ratio of 4.79, which compares to a historical PB ratio of 3.86. Additionally, the stock is trading at a price to sales ratio of 26.30. The company has a market capitalization of USD 293.59 million.
- Curis Inc.'s stock advanced 1.65% to close Monday's session at USD 2.46. The share price vacillated between USD 2.34 and USD 2.50. The stock recorded a trading volume of 0.19 million shares, which was below its 50-day daily average volume of 0.37 million shares and 52-week average volume of 0.87 million shares. Over the last three days Curis Inc.'s shares have declined by 1.20% and in the past one week the stock has moved down 8.55%. Moreover, in the last six months the stock has lost 21.15% while year to date the shares have picked up 64.00%. On a compounded total return basis, the company has returned 87.79% in the past one year. The stock is trading at a price to book ratio of 4.09, which compares to historical PB ratio of 4.39. Additionally, the stock is trading at a price to sales ratio of 39.95. The company has a market capitalization of USD 315.85 million.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice